Pharmidex partners in European Commission H2020 award
May 21, 2017

Pharmidex joins Horizon 2020 EU project to work on radioactive contamination

Pharmidex partners in European Commission H2020 award

This project aims to stimulate intersectoral and international collaboration within Europe and with an ICPC country, Kazakhstan, in the area of novel nanoporous and nanostructured adsorbents for the treatment of very serious health conditions associated with acute and chronic exposure to external radiation and uptake of heavy metals and radiation as a consequence of accidental, occupational or deliberate activities and events.


This can dramatically lower the quality of life of the people affected and at present the treatment available is costly and inefficient. Radioactive contamination is a particularly serious problem in two of the countries participating in this project, namely, Ukraine and Kazakhstan, on large territories of the Chernobyl zone and around Semipalatinsk nuclear test site, respectively.


A large number of people are affected by living in the areas with elevated level of radioactivity with uncertain long-term consequences to their health and the health of future generations.


The expected impact of the project results is development of efficient and cost-effective methods of protection of first responders, population and cancer patients treated with radiotherapy from elevated doses of external and incorporated radiation and for occupational health protection of personnel working and the population living in areas contaminated with heavy metals.


Please find more information on the following web page: http://cordis.europa.eu/project/rcn/207057_en.html

June 16, 2026
This well-deserved appointment marks an important milestone in a remarkable career spanning more than 22 years at Pharmidex . Over the years, Dr Chishty has made a significant contribution to the growth of our DMPK capabilities, applying his extensive expertise in Drug Metabolism and Pharmacokinetics to support successful drug discovery and development programmes for clients worldwide. His scientific leadership, dedication and commitment to excellence have been instrumental in strengthening our services and supporting the continued success of Pharmidex . As we continue to grow and support innovative biopharmaceutical companies, we look forward to the impact Dr Chishty will make in this new role. Please join us in congratulating Dr Mansoor Chishty on this achievement and wishing him every success as Director of DMPK.
June 12, 2026
At Pharmidex , we know that great teams are built through collaboration, resilience and shared experiences. Our recent football event brought colleagues together to promote wellbeing, encourage physical activity and strengthen the relationships that help us succeed both on the pitch and in the laboratory. The qualities that drive success in sport, teamwork, dedication and determination are the same values that underpin scientific excellence every day at Pharmidex . As the world looks ahead to the excitement of World Football 2026, we're proud to celebrate the positive impact sport has in bringing people together, inspiring healthy lifestyles, and creating stronger communities. 🔬 Advancing science 🤝 Building stronger teams 💪 Promoting wellbeing ⚽ Celebrating our passion for sport And while football fans may be singing "It's coming home"... at Pharmidex we're convinced that "It's coming lab!" 🧪⚽ From the pitch to the lab, we're proud to champion teamwork, innovation, and a shared passion for achieving great results.
June 8, 2026
Pharmidex is seeking an experienced and driven Principal / Senior Translational Pharmacologist to join our growing Translational Research team and lead innovative ophthalmology programmes. We're looking for a senior scientist with expertise in ophthalmology, ocular disease models, and translational pharmacology who is ready to make a real impact in a dynamic CRO environment. ✅ Competitive salary and benefits ✅ High-visibility scientific leadership role ✅ Opportunities to present at international conferences ✅ Direct impact on advancing innovative medicines toward the clinic
More Posts